A Phase IV Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma That is Not Responding to Four or More Standard Treatments or Has Come Back After Several Standard Treatments

NCT07881835 · clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
75
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer